Latest filing published 29 Mar 2024 for AN2 Therapeutics, Inc..
Insider track record
Kevin Michael Krause: trading record in brief
This profile gathers the share dealings of Kevin Michael Krause in AN2 Therapeutics, Inc. Over a trading history stretching from 2 January 2024 to 15 March 2024, the count stands at 7 filings.
Every open-market trade on record is a sale: 2 sales worth €183k. Other entries cover 2 share grants and 3 option exercises.
Most recently, on 29 March 2024, the filings show a share grant in AN2 Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kevin Michael Krause
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 shares0Common StockSEC:0001610717-24-000193:0
- 30,000 shares0Common StockSEC:0001610717-24-000167:0
- 2,417 shares@ US$0.4248.5% of flowCommon StockSEC:0001610717-24-000027:0
- 2,583 shares@ US$0.4251.5% of flowCommon StockSEC:0001610717-24-000014:0
4 of 4 declarations
